Parkinson Disease
Conditions
Interventions
Longitudinal, prospective concurrent, uncontrolled study. There will be 36 individuals with Parkinson's disease (PD) who will be evaluated in the motor aspect (UPDRS - motor part), gait analysis (imag
Sponsors
Universidade de São Paulo
Universidade de São Paulo
Eligibility
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: Parkinson's Disease sufferers; both sexes; over 50 years of age; stages 1 to 3 on the Hoehn-Yahr Scale; able to ambulate and remain standing; being monitored by a neurologist; taking levodopa
Exclusion criteria
Exclusion criteria: Use of walking aids; freezing; previous lung involvement; smokers; history of thoracic surgery; with a diagnosis of associated dementia syndrome; needle phobia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that vital capacity (volume in liters) will increase immediately after the intervention and that this volume will be maintained at follow-up by at least 150mL. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that there will be a 10% reduction in the post-intervention time measured when compared to the pre-intervention time to perform the task of getting up from a chair and walking for 10 feet.;The increase in stride length in the gait cycle is expected to be 10% of the pre-intervention assessed stride value. | — |
Countries
Brazil
Contacts
Public ContactAriany Tahara
Universidade de São Paulo
Outcome results
None listed